Repozitorij Medicinskog fakulteta Sveučilišta u Zagrebu

Esomeprazole versus pantoprazole for healing erosive oesophagitis

Včev, Aleksandar and Begić, Ivana and Ostojić, Rajko and Jurčić, Dragan and Božić, Dubravko and Soldo, Ivan and Gmajnić, Rudika and Kondža, Goran and Khaznadar, Eyad and Mićunović, Nikola (2006) Esomeprazole versus pantoprazole for healing erosive oesophagitis. Collegium antropologicum, 30 (3). pp. 519-522. ISSN 0350-6134 (Print)

[img]
Preview
PDF
Download (80Kb) | Preview

    Croatian abstract

    Cilj ovog rada je bio komparirati učinkovitost esomeprazola i pantoprazola u cijeljenju erozivnog ezofagitisa (EE) i nestanku simptoma gastroezofagealne refluksne bolesti (GERB). U ovu multicentričnu, randomiziranu, jednostruko slijepu studiju je bilo uključeno 180 bolesnika s endoskopski dijagnosticiranim GERB-om i dobivali su esomeprazol 40 mg/dan (90 bolesnika) ili pantoprazol 40 mg/dan (90 bolesnika). Nakon 4. i 8. tjedna terapije kontrolirani su radi dokaza cijeljenja EE i nestanka simptoma GERB-a. Esomeprazol bio je statistički značajno učinkovitiji od pantoprazola u cijeljenju EE nakon 4 tjedna liječenja (77.8% nasuprot 72.2%). Nakon 8 tjedana liječenja učinkovitost im je bila podjednaka (92.2% nasuprot 91.1%). Postotak bolesnika bez simptoma GERB-a je bio podjednak nakon 4. i 8. tjedna liječenja u obje skupine.

    English abstract

    The aim of this study was to compare the efficacy of esomeprazole and pantoprazole with regard to healing and relief from gastroesophageal reflux disease-related symptoms. I this multicentre, randomized, single-blind study 180 patients (ITT population) diagnosed with endoscopically proven GERD grade A,B,C received esomeprazole (40 mg once daily (o.d.), n = 90) orpantoprazole (40 mg o.d., n = 90). Healing and relief from GERD-related symptoms were assessed at first and final visit (after 4 or 8 weeks of treatment). Esomeprazole 40 mg provided significantly greater healing than pantoprazole 40 mg after 4 weeks of treatment in patients with EE (77.8% vs. 72.2%). Esomeprazole-treated patients were healed after up to 8 weeks of treatment similar those treated with pantoprazole (92.2% vs. 91.1%). The proportion of heartburn-free days was similar in patients treated with esomeprazole and to those treated with pantoprazole.

    Item Type: Article
    MeSH: Anti-Ulcer Agents - adverse effects - therapeutic use ; Benzimidazoles - adverse effects - therapeutic use ; Gastroesophageal Reflux - classification - drug therapy - physiopathology ; Omeprazole - adverse effects - analogs & derivatives - therapeutic use ; Sulfoxides - adverse effects - therapeutic use ; 2-Pyridinylmethylsulfinylbenzimidazoles ; Aged ; Female ; Humans ; Male ; Middle Aged ; Severity of Illness Index ; Treatment Outcome
    Divisions: Katedra za internu medicinu
    Depositing User: Boris Čičovački
    Status: Published
    Creators:
    CreatorsEmail
    Včev, Aleksandar
    Begić, Ivana
    Ostojić, Rajko
    Jurčić, Dragan
    Božić, Dubravko
    Soldo, Ivan
    Gmajnić, Rudika
    Kondža, Goran
    Khaznadar, Eyad
    Mićunović, Nikola
    Date: September 2006
    Date Deposited: 14 Oct 2008
    Last Modified: 23 Sep 2011 18:10
    Subjects: /
    Related URLs:
      URI: http://medlib.mef.hr/id/eprint/471

      Actions (login required)

      View Item

      Document Downloads

      More statistics for this item...